SUBSCRIBE
SUBSCRIBE
News   Drug Development

Spain’s Zeltia Says Latest Yondelis Results Hopeful

November 22, 2005 | 
1 min read
MADRID, Nov 22 (Reuters) - Spanish chemicals and biotech company Zeltia (ZEL.MC: Quote, Profile, Research) said on Tuesday recent tests with its marine based anti-cancer drug Yondelis had shown positive results.
Preclinical Europe
Johnson & Johnson Family of Companies
MORE ON THIS TOPIC
World Management Team in office silhouette 3d rendering
Drug Development
The Gap Between the Administration’s Pro-Innovation Words and Policy
July 14, 2025
 · 
6 min read
 · 
Lori Ellis
3d rendering medical heart in yellow background
Cardiovascular disease
AstraZeneca’s Baxdrostat Pushes Blood Pressure Lower in Phase III Trial
July 14, 2025
 · 
1 min read
 · 
Dan Samorodnitsky
Pictured: Takeda sign at its office in Massachusetts
Neuroscience
Takeda Establishes Lead in Narcolepsy Race With Back-to-Back Phase III Wins
July 14, 2025
 · 
2 min read
 · 
Tristan Manalac
vector illustration arrows miss the target board, concept of lost in focus, failure, fail, mistake
Depression
After Three Strikes, Relmada Abandons Depression Drug Esmethadone 
July 14, 2025
 · 
2 min read
 · 
Tristan Manalac